Does double J stenting during transurethral resection of a bladder tumor increase the risk for metachronous upper urinary tract urothelial cancer development?
Main Authors: | M.C. Hupe, L. Dormayer, T. Ozimek, J.P. Struck, M.J.P. Hennig, M. Klee, C.A.J. Von Klot, M.A. Kuczyk, A.S. Merseburger, M.W. Kramer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320337277 |
Similar Items
-
Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer
by: Marie C. Hupe, et al.
Published: (2020-02-01) -
Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy—Real-World Clinical Impressions and Comparative Review of the Literature
by: Christian Fuhrmann, et al.
Published: (2020-05-01) -
Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature
by: Hossein Tezval, et al.
Published: (2012-10-01) -
Recurrent papillary renal cell carcinoma with concomitant ipsilateral upper urinary tract urothelial carcinoma and metachronous urothelial carcinoma of the bladder
by: Pooya Banapour, MD, et al.
Published: (2018-03-01) -
Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas
by: Ezgi HACIHASANOĞLU, et al.
Published: (2021-01-01)